Low-Level Laser Therapy for Prevention of Oral Mucositis
A Phase II Prospective Trial of Low-Level Laser Therapy for Prevention of Oral Mucositis in Patients Receiving Chemotherapy and Radiation for Head and Neck Cancer
Sponsor: Barbara Ann Karmanos Cancer Institute
This NA trial investigates Mucositis and is currently completed. Barbara Ann Karmanos Cancer Institute leads this study, which shows 8 recorded versions since 2016 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Mar 2023 — Jul 2024 [monthly]
Completed NA
Status: Unknown Status → Completed
-
Jan 2021 — Mar 2023 [monthly]
Unknown Status NA
-
Jun 2019 — Jan 2021 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
▶ Show 3 earlier versions
-
Jun 2018 — Jun 2019 [monthly]
Recruiting NA
-
Jun 2017 — Jun 2018 [monthly]
Recruiting NA
Phase: PHASE2 → NA
-
Jan 2017 — Jun 2017 [monthly]
Recruiting PHASE2
First recorded
Mar 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Barbara Ann Karmanos Cancer Institute
- National Cancer Institute (NCI)
For direct contact, visit the study record on ClinicalTrials.gov .